106 related articles for article (PubMed ID: 3149800)
1. Plasma fibronectin level in patients with connective tissue diseases.
Ciobanu V; Popescu D; Bălună R; Belascu I; Barac D; Tarnavschi R; Caralicea M
Med Interne; 1988; 26(4):267-71. PubMed ID: 3149800
[TBL] [Abstract][Full Text] [Related]
2. Concentration of fibronectin and granulocyte elastase in plasma of patients with systemic connective-tissue diseases.
Schneider M; Lohmann J; Krummenerl T; Gerlach U
Int J Tissue React; 1987; 9(4):355-9. PubMed ID: 3497902
[TBL] [Abstract][Full Text] [Related]
3. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of nailfold capillary changes for the development of connective tissue disease in children and adolescents with primary raynaud phenomenon: a follow-up study of 250 patients.
Pavlov-Dolijanović S; Damjanov N; Ostojić P; Susić G; Stojanović R; Gacić D; Grdinić A
Pediatr Dermatol; 2006; 23(5):437-42. PubMed ID: 17014637
[TBL] [Abstract][Full Text] [Related]
5. Fibronectin and other DIC-related variables in patients with moderately severe infections receiving cryoprecipitate.
Brodin B; Hesselvik F; Blombäck M; Cedergren B; Lieden G; Maller R; Strindberg J
Scand J Clin Lab Invest Suppl; 1985; 178():57-65. PubMed ID: 3937219
[TBL] [Abstract][Full Text] [Related]
6. von Willebrand factor in the plasma of patients with rheumatic diseases.
Duţu A; Rus V; Boloşiu HD; Parasca I; Cristea A; Malide D
Med Interne; 1989; 27(4):273-8. PubMed ID: 2617082
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism.
Gonzalez-Lopez L; Gamez-Nava JI; Jhangri GS; Ramos-Remus C; Russell AS; Suarez-Almazor ME
J Rheumatol; 1999 Mar; 26(3):540-5. PubMed ID: 10090159
[TBL] [Abstract][Full Text] [Related]
8. [Changes in fibronectin concentration during therapeutic plasmapheresis. Therapeutic effectiveness of selective removal of fibronectin in immune complex pathology].
Vasil'ev SA; Savchenko VG; Gorodetskiĭ VM; Ermolin GA; Kotelianskiĭ VE
Ter Arkh; 1984; 56(6):35-9. PubMed ID: 6236575
[TBL] [Abstract][Full Text] [Related]
9. Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality.
Ward MM; Donald F
Arthritis Rheum; 1999 Apr; 42(4):780-9. PubMed ID: 10211894
[TBL] [Abstract][Full Text] [Related]
10. [Pentose phosphate pathway of carbohydrate metabolism in various systemic diseases of the connective tissue].
Shishkin VI; Kudriavtseva GV; Makarov SA
Vopr Med Khim; 1988; 34(6):40-5. PubMed ID: 3238942
[TBL] [Abstract][Full Text] [Related]
11. Determination of plasma fibronectin and serum C-reactive protein in patients with cerebrovascular events.
Pençe S; Yilmaz G; Yilmaz N; Kocoglu H; Namiduru E; Yüncü M; Gökalp N
Int J Clin Pract; 2003 Mar; 57(2):91-5. PubMed ID: 12661789
[TBL] [Abstract][Full Text] [Related]
12. [Determination of plasma fibronectin (Fn) levels. Comparison between normal subjects and patients with various pathological conditions].
Gironi A; Niccolai J; Fabbri LP; Niccolai M; Chisci C
Quad Sclavo Diagn; 1982 Dec; 18(4):392-405. PubMed ID: 6764670
[TBL] [Abstract][Full Text] [Related]
13. Occurrence of fibronectin-fibrin complexes in plasma of patients with multimorbidity due to the inflamm-aging phenomenon.
Pupek M; Pawłowicz R; Lindner K; Krzyżanowska-Gołąb D; Lemańska-Perek A; Panaszek B; Kątnik-Prastowska I
Exp Gerontol; 2016 May; 77():19-28. PubMed ID: 26883337
[TBL] [Abstract][Full Text] [Related]
14. [Levels of endogenous plasma cortisol in patients with rheumatoid arthritis and other diffuse connective tissue diseases].
Kucera M; Topolcan O; Racek J; Panzner P
Vnitr Lek; 1995 Jul; 41(7):449-53. PubMed ID: 7571478
[TBL] [Abstract][Full Text] [Related]
15. Serial analysis of fibronectin concentration in sera from septic patients.
Bălună R; Tarnavschi R; Barac D; Belascu I; Georgescu H
Med Interne; 1988; 26(1):85-90. PubMed ID: 3399819
[TBL] [Abstract][Full Text] [Related]
16. Citrullination of fibronectin in rheumatoid arthritis synovial tissue.
Chang X; Yamada R; Suzuki A; Kochi Y; Sawada T; Yamamoto K
Rheumatology (Oxford); 2005 Nov; 44(11):1374-82. PubMed ID: 16105911
[TBL] [Abstract][Full Text] [Related]
17. Fibronectin in plasma and synovial fluid of patients with rheumatic diseases.
Duţu A; Vlaicu-Rus V; Boloşiu HD; Parasca I; Cristea A
Med Interne; 1986; 24(1):61-8. PubMed ID: 3518030
[TBL] [Abstract][Full Text] [Related]
18. [Fibronectin and other immunologic parameters in chronic polyarthritis].
Siegmeth W; Minar E; Graninger W; Pirich K; Zazgornik J
Z Rheumatol; 1984; 43(1):27-9. PubMed ID: 6201023
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological study of patients with connective tissue diseases in Brazil.
Almeida Mdo S; Bértolo MB; Da Silva BB; De Deus Filho A; Almeida MM; Veras FF; Mendes LC
Trop Doct; 2005 Oct; 35(4):206-9. PubMed ID: 16354468
[TBL] [Abstract][Full Text] [Related]
20. [Undifferentiated connective tissue disease: clinical and serological profile of 578 patients followed for five years: disease course, prognosis and therapy].
Bodolay E; Szegedi G
Orv Hetil; 2002 Feb; 143(5):229-33. PubMed ID: 11875835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
